Profiling Prostate Cancer Therapeutic Resistance

The major challenge in the treatment of patients with advanced lethal prostate cancer is therapeutic resistance to androgen-deprivation therapy (ADT) and chemotherapy. Overriding this resistance requires understanding of the driving mechanisms of the tumor microenvironment, not just the androgen rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wade, Cameron A., Kyprianou, Natasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877765/
https://www.ncbi.nlm.nih.gov/pubmed/29562686
http://dx.doi.org/10.3390/ijms19030904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877765/
https://www.ncbi.nlm.nih.gov/pubmed/29562686
http://dx.doi.org/10.3390/ijms19030904

Ejemplares similares